Cancer survivors had a higher risk of severe maternal morbidity than patients without a cancer diagnosis, according to a study published Nov. 16 in JAMA Network Open.
Researchers from Los Angeles-based University of Southern California analyzed National Inpatient Sample data on 28,360,443 hospital deliveries from 2016 to 2023 to assess pregnancy trends and outcomes among patients with a current or past cancer diagnosis.
Here are four notes from the study:
- Hospital deliveries among cancer survivors rose from 30.1 per 10,000 deliveries in 2016 to 45.6 per 10,000 in 2023.
- Cancer survivors experienced severe maternal morbidity at a rate of 11.9 per 1,000 hospital deliveries, compared with 6.8 per 1,000 among patients without cancer and 48.2 per 1,000 among patients currently living with cancer.
- The inpatient maternal mortality rate was 273.0 per 100,000 hospital deliveries among patients currently living with cancer, compared with 7.0 per 100,000 among patients without cancer.
- Among cancer survivors, 57.6% of deliveries were full term, compared with 39.6% among patients currently living with cancer.
Read the full study here.
